| A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) (NCT05121948) | HiberCell, Inc. | 2022-02-23 |
| Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer (NCT03081858) | Lipac Oncology LLC | 2018-05-17 |
| Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab (NCT03263039) | Erasmus Medical Center | 2017-08-21 |
| A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer (NCT02897765) | BioNTech US Inc. | 2016-10-01 |
| Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors (NCT02318329) | Five Prime Therapeutics, Inc. | 2014-11-01 |
| A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine (NCT02101931) | Princess Al-Johara Al-Ibrahim Cancer Research Center | 2014-03-01 |
| Adjuvant Radiation for High Risk Bladder Cancer (NCT01954173) | Emory University | 2013-07-22 |
| Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer (NCT01639521) | University of Southern California | 2013-05-01 |
| Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder (NCT01382706) | University of Southern California | 2011-06-13 |
| Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer (NCT01282333) | National Cancer Institute (NCI) | 2011-01-01 |
| Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery (NCT01108003) | Roswell Park Cancer Institute | 2010-04-01 |
| Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC (NCT00859339) | Noah Hahn, M.D. | 2009-03-01 |
| Pazopanib in Treating Patients With Metastatic Urothelial Cancer (NCT00471536) | National Cancer Institute (NCI) | 2008-08-01 |
| Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function (NCT00478361) | M.D. Anderson Cancer Center | 2007-04-01 |
| VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00407485) | National Cancer Institute (NCI) | 2006-11-01 |
| Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium (NCT00363883) | National Cancer Institute (NCI) | 2006-06-01 |
| Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer (NCT01824329) | University of Michigan | 2006-06-01 |
| Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium (NCT00112905) | National Cancer Institute (NCI) | 2005-10-01 |
| Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract (NCT00112671) | National Cancer Institute (NCI) | 2005-04-01 |
| Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma (NCT01828736) | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 2004-02-09 |
| Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma (NCT00072150) | National Cancer Institute (NCI) | 2003-10-01 |
| Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00004856) | National Cancer Institute (NCI) | 2002-07-01 |
| Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium (NCT00028756) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-10-01 |
| Arsenic Trioxide in Treating Patients With Urothelial Cancer (NCT00009867) | National Cancer Institute (NCI) | 2000-12-01 |
| Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer (NCT00005831) | National Cancer Institute (NCI) | 2000-03-01 |
| Gene Therapy in Treating Patients With Advanced Bladder Cancer (NCT00003167) | National Cancer Institute (NCI) | 1998-05-01 |